Skip to content

Exploring the clinical efficacy of spleen-enhancing and blood-activating method for the treatment of femoral head necrosis in the peri-collapse stage based on the blood transport condition of the rotary internal femoral artery

Exploring the clinical efficacy of spleen-enhancing and blood-activating method for the treatment of femoral head necrosis in the peri-collapse stage based on the blood transport condition of the rotary internal femoral artery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000421
Enrollment
Unknown
Registered
2026-02-25
Start date
2024-03-15
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrosis of the femoral head

Interventions

Control group:Multi-channel treatment with traditional Chinese medicine combined with other conservative treatment methods and western medicine surgical treatment
Experimental group:Traditional Chinese medicine multi-channel treatment combined with other conservative treatment methods

Sponsors

Wangjing Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1)Meeting the diagnostic criteria for femoral head necrosis; 2) ARCO stage II-III A (peri-collapse stage); 3) Age ranging from 18 to 55 years old; 4) DSA angiography results indicating type I and type IIA; 5) TCM syndrome differentiation as phlegm and blood stasis blocking the meridians; 6) Follow up time = 2 years, complete imaging and clinical data.

Exclusion criteria

Exclusion criteria: 1)previous hip-preserving surgery; 2) continued systemic corticosteroid therapy required for co-existing disease; 3)concomitant hip disorders including developmental dysplasia of the hip, pigmented villonodular synovitis, rheumatoid arthritis with hip involvement, or ankylosing spondylitis with hip involvement; 4) psychiatric disease, cerebrovascular disorder, or other neurological conditions precluding reliable follow-up; 5)indistinct or un-interpretable imaging data.

Design outcomes

Primary

MeasureTime frame
Imaging efficacy evaluation;Harris feature rating;

Secondary

MeasureTime frame
Classification of femoral head bone marrow edema ;Classification of hip joint effusion;VAS rating;

Countries

China

Contacts

Public ContactHe Haijun

Department of Bone and Joint, Wangjing Hospital, China Academy of Chinese Medical Sciences

drhjhe@126.com+86 138 1143 6750

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026